Influenza Virus and Epstein-Barr Virus Peptides

Home » What we do » Catalogue Peptides » Influenza virus and Epstein-Barr virus peptides

Purified CEF peptides derived from human Epstein-Barr virus (EBV), cytomegalovirus (CMV) and influenza virus proteins. These short viral peptides can induce IFN-γ secretion of human CD8+ T cells and be used as positive controls in immune cell stimulation assays. They can also serve as invaluable tools for studying viral protein structure and for the design of targeted interventions.

Supplied freeze-dried, purified and ready to ship in 1mg amounts.

Influenza virus, Epstein-Barr virus and Cytomegalovirus peptides

CEF product	Peptide sequence	Catalog no.	Quantity	GBP
CEF1, Influenza Matrix Protein M1 (58 – 66)	GILGFVFTL	AB-CEF001	1 mg	£115
CEF2, Influenza Virus PA (46 – 54)	FMYSDFHFI	AB-CEF002	1 mg	£115
CEF3, Influenza Virus M1 (13 – 21)	SIIPSGPLK	AB-CEF003	1 mg	£115
CEF4, Influenza Virus NP (342 – 351)	RVLSFIKGTK	AB-CEF004	1 mg	£115
CEF5, Influenza Virus NP (91 – 99)	KTGGPIYKR	AB-CEF005	1 mg	£115
CEF6, Influenza Virus NP	LPFDKTTVM	AB-CEF006	1 mg	£115
CEF7, Influenza Virus NP (380 – 388)	ELRSRYWAI	AB-CEF007	1 mg	£115
CEF8, Influenza Virus NP (383 – 391)	SRYWAIRTR	AB-CEF008	1 mg	£115
CEF9, Influenza Virus M1 128 – 135	ASCMGLIY	AB-CEF009	1 mg	£115
CEF10, Epstein – Barr Virus LMP2 (426 – 434)	CLGGLLTMV	AB-CEF010	1 mg	£115
CEF11, Epstein – Barr Virus BMLF1 (280 – 288)	GLCTLVAML	AB-CEF011	1 mg	£115
CEF12, Epstein – Barr Virus latent NA3B (399 – 408), AVF	AVFDRKSDAK	AB-CEF012	1 mg	£115
CEF14, Epstein – Barr Virus RTA Protein (28 – 37)	DYCNVLNKEF	AB-CEF014	1 mg	£115
CEF15, Epstein – Barr Virus Lytic Cycle Protein BZLF – 1(190 – 197)	RAKFKQLL	AB-CEF015	1 mg	£115
CEF16, Epstein – Barr Virus latent NA – 3A (337 – 347)	FLRGRAYGL	AB-CEF016	1 mg	£115
CEF17, Epstein – Barr Virus latent NA – 3A (158 – 166)	QAKWRLQTL	AB-CEF017	1 mg	£115
CEF18, Epstein – Barr Virus latent NA – 3C (258 – 266)	RRIYDLIEL	AB-CEF018	1 mg	£115
CEF19, Epstein – Barr Virus latent NA – 3A (458 – 466)	YPLHEQHGM	AB-CEF019	1 mg	£115
CEF20, Cytomegalovirus, CMV pp65 (495 – 503)	NLVPMVATV	AB-CEF020	1 mg	£115
CEF21, Cytomegalovirus, CMV pp65 (417 – 426)	TPRVTGGGAM	AB-CEF021	1 mg	£115
CEF22, Cytomegalovirus, CMV pp65 (378 – 389)	SDEEEAIVAYTL	AB-CEF022	1 mg	£115
CEF23, Cytomegalovirus, CMV pp65 (123 – 131)	IPSINVHHY	AB-CEF023	1 mg	£115
CEF24, Influenza Virus PB1 Peptide (591 – 599)	VSDGGPNLY	AB-CEF024	1 mg	£115
CEF25, Influenza Virus NP (44 – 52)	CTELKLSDY	AB-CEF025	1 mg	£115
CEF26, Influenza Virus NP (265 – 274)	ILRGSVAHK	AB-CEF026	1 mg	£115
CEF27, Epstein – Barr Virus BRLF – 1 lytic (148 – 156)	RVRAYTYSK	AB-CEF027	1 mg	£115
CEF28, Epstein – Barr Virus latent NA – 3A (603 – 611)	RLRAEAQVK	AB-CEF028	1 mg	£115
CEF29, Epstein – Barr Virus latent NA – 3B (416 – 424)	IVTDFSVIK	AB-CEF029	1 mg	£115
CEF30, Epstein – Barr Virus BRLF1 (134 – 142)	ATIGTAMYK	AB-CEF030	1 mg	£115
CEF31, Epstein – Barr Virus latent NA – 3A (379 – 387)	RPPIFIRRL	AB-CEF031	1 mg	£115
CEF32, Epstein – Barr Virus latent NA – 3C (281 – 290)	EENLLDFVRF	AB-CEF032	1 mg	£115
CEF33, Cytomegalovirus, HCMV pp65	EFFWDANDIY	AB-CEF033	1 mg	£115

9 September 2026

Epitope Mapping: Methods, Applications and Peptide-Based Approaches

A practical guide to linear epitope mapping: how overlapping peptide libraries and microarrays map antibody and T-cell epitopes and how to get reliable data.